| Paralogue | Variant | Associated Disease | Mapping Quality | Consensus | Pubmed |
|---|---|---|---|---|---|
| SCN1A | P1451L | Myoclonic epilepsy of infancy | High | 9 | 17054684 |
| SCN1A | P1451S | Dravet syndrome C ? | High | 9 | 21248271 |
| SCN1A | P1451T | Dravet syndrome | High | 9 | 26096185 |
To assess whether the paralogue annotation here confidently predicts that variation at this residue is pathogenic, it is important to check the reports in the Pubmed links above to ascertain that the mutations in these paralogues have been proved likely to be disease-causing. It is also important to check that the direction of effect of the variant in the paralogue is compatible with your observed phenotype in SCN5A.
| SCN5A | GYLALLQVATFKGWMDIMYAAVDSRGYEEQ>P<QWEYNLYMYIYFVIFIIFGSFFTLNLFIGV | 1468 |
| SCN1A | GYLSLLQVATFKGWMDIMYAAVDSRNVELQ>P<KYEESLYMYLYFVIFIIFGSFFTLNLFIGV | 1481 |
| SCN2A | GYLSLLQVATFKGWMDIMYAAVDSRNVELQ>P<KYEDNLYMYLYFVIFIIFGSFFTLNLFIGV | 1471 |
| SCN3A | GYLALLQVATFKGWMDIMYAAVDSRDVKLQ>P<VYEENLYMYLYFVIFIIFGSFFTLNLFIGV | 1466 |
| SCN4A | GYLSLLQVATFKGWMDIMYAAVDSREKEEQ>P<QYEVNLYMYLYFVIFIIFGSFFTLNLFIGV | 1293 |
| SCN7A | GFLSLLQVATFNGWITIMNSAIDSVAVNIQ>P<HFEVNIYMYCYFINFIIFGVFLPLSMLITV | 1191 |
| SCN8A | GYLALLQVATFKGWMDIMYAAVDSRKPDEQ>P<KYEDNIYMYIYFVIFIIFGSFFTLNLFIGV | 1462 |
| SCN9A | GYLSLLQVATFKGWTIIMYAAVDSVNVDKQ>P<KYEYSLYMYIYFVVFIIFGSFFTLNLFIGV | 1444 |
| SCN10A | GYLALLQVATFKGWMDIMYAAVDSREVNMQ>P<KWEDNVYMYLYFVIFIIFGGFFTLNLFVGV | 1416 |
| SCN11A | AYLALLQVATFKGWMDIIYAAVDSTEKEQQ>P<EFESNSLGYIYFVVFIIFGSFFTLNLFIGV | 1306 |
| CACNA1A | ALLTLFTVSTGEGWPQVLKHSVDATFENQG>P<SPGYRMEMSIFYVVYFVVFPFFFVNIFVAL | 1509 |
| CACNA1B | ALLTLFTVSTGEGWPMVLKHSVDATYEEQG>P<SPGYRMELSIFYVVYFVVFPFFFVNIFVAL | 1415 |
| CACNA1C | AMMALFTVSTFEGWPELLYRSIDSHTEDKG>P<IYNYRVEISIFFIIYIIIIAFFMMNIFVGF | 1164 |
| CACNA1D | AMMALFTVSTFEGWPALLYKAIDSNGENIG>P<IYNHRVEISIFFIIYIIIVAFFMMNIFVGF | 1170 |
| CACNA1E | ALLTLFTVSTGEGWPQVLQHSVDVTEEDRG>P<SRSNRMEMSIFYVVYFVVFPFFFVNIFVAL | 1421 |
| CACNA1F | AMMALFTVSTFEGWPALLYKAIDAYAEDHG>P<IYNYRVEISVFFIVYIIIIAFFMMNIFVGF | 1135 |
| CACNA1G | ALMSLFVLASKDGWVDIMYDGLDAVGVDQQ>P<IMNHNPWMLLYFISFLLIVAFFVLNMFVGV | 1535 |
| CACNA1H | ALMSLFVLSSKDGWVNIMYDGLDAVGVDQQ>P<VQNHNPWMLLYFISFLLIVSFFVLNMFVGV | 1553 |
| CACNA1I | ALMSLFVLASKDGWVNIMYNGLDAVAVDQQ>P<VTNHNPWMLLYFISFLLIVSFFVLNMFVGV | 1429 |
| CACNA1S | AMMSLFTVSTFEGWPQLLYKAIDSNAEDVG>P<IYNNRVEMAIFFIIYIILIAFFMMNIFVGF | 1063 |
| cons | > < |
| Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
|---|---|---|---|---|---|
| p.P1438L | c.4313C>T | Inherited Arrhythmia | BrS | rs199473248 | SIFT: deleterious Polyphen: benign |
| Reports | Inherited Arrhythmia | BrS | The occurrence of Brugada syndrome and isolated cardiac conductive disease in the same family could be due to a single SCN5A mutation or to the accidental association of both diseases. Europace. 2008 10(1):79-85. 18156160 | ||
| Inherited Arrhythmia | BrS | An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm. 2010 7(1):33-46. 20129283 | |||
| Inherited Arrhythmia | BrS | Paralogue annotation identifies novel pathogenic variants in patients with Brugada syndrome and catecholaminergic polymorphic ventricular tachycardia. J Med Genet. 2014 51(1):35-44. doi: 10.1136/jmedgenet-2013-101917. 24136861 | |||